Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CEO | PATEL DINESH V PH D | Aug 11, 2026 | Sell | $5.09M | 34,239 |
| CEO | PATEL DINESH V PH D | Aug 10, 2026 | Sell | $9.81M | 65,761 |
| Director | Waddill William D. | Jun 23, 2026 | Sell | $1.06M | 9,000 |
| Director | Waddill William D. | Jun 10, 2026 | Sell | $969.12K | 9,000 |
| Director | Waddill William D. | May 29, 2026 | Sell | $896.76K | 9,000 |
| CEO | PATEL DINESH V PH D | May 12, 2026 | Sell | $7.51M | 75,000 |
| Director | Giraudo Bryan | May 8, 2026 | Sell | $600K | 6,000 |
| Director | Giraudo Bryan | May 8, 2026 | Sell | $513K | 5,130 |
| Director | Giraudo Bryan | May 7, 2026 | Sell | $3.61M | 36,000 |
| Director | Giraudo Bryan | May 7, 2026 | Sell | $1.2M | 12,000 |
| CFO | Ali Asif | Apr 20, 2026 | Sell | $184.57K | 1,750 |
| Chief Medical Officer | MOLINA ARTURO MD | Mar 26, 2026 | Sell | $1.57M | 15,000 |
| Director | SELICK HAROLD E | Mar 26, 2026 | Sell | $2.52M | 24,000 |
| CFO | Ali Asif | Mar 26, 2026 | Sell | $2.58M | 24,765 |
| CEO | PATEL DINESH V PH D | Mar 25, 2026 | Sell | $5.52M | 54,641 |
| CEO | PATEL DINESH V PH D | Mar 24, 2026 | Sell | $5.96K | 59 |
| Director | Williams Lewis T | Feb 17, 2026 | Sell | $1.48M | 18,000 |
| Director | Waddill William D. | Feb 6, 2026 | Sell | $1.67M | 20,000 |
| CFO | Ali Asif | Jan 27, 2026 | Sell | $2.33M | 28,000 |
| CFO | Ali Asif | Jan 27, 2026 | Sell | $1.51M | 18,203 |
| Chief Medical Officer | MOLINA ARTURO MD | Jan 27, 2026 | Sell | $410K | 5,000 |
| CEO | PATEL DINESH V PH D | Jan 27, 2026 | Sell | $338.42K | 4,068 |
| Chief Medical Officer | MOLINA ARTURO MD | Jan 26, 2026 | Sell | $411.4K | 5,000 |
| CEO | PATEL DINESH V PH D | Jan 26, 2026 | Sell | $897.54K | 10,685 |
| CEO | PATEL DINESH V PH D | Jan 26, 2026 | Sell | $1.19M | 14,205 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
